American Cancer Society Journals shared a post on LinkedIn:
“CANCER is pleased to share a new supplement from the National Cancer Institute (NCI) Cancer Treatment Tolerability Consortium. It features eight articles that examine new methods for assessing cancer treatment tolerability.
This work highlights how integrating clinician- and patient-reported data can deepen understanding of how treatment side effects affect patient experiences, decision-making, and outcomes.
Watch lead author Amylou Dueck, PhD, summarize the issue’s contents and explore the full supplement here.”
Proceed to the video attached to the post.
More posts featuring American Cancer Society Journals on OncoDaily.